SG11201400218YA - Methods for increasing osteoblastic function - Google Patents
Methods for increasing osteoblastic functionInfo
- Publication number
- SG11201400218YA SG11201400218YA SG11201400218YA SG11201400218YA SG11201400218YA SG 11201400218Y A SG11201400218Y A SG 11201400218YA SG 11201400218Y A SG11201400218Y A SG 11201400218YA SG 11201400218Y A SG11201400218Y A SG 11201400218YA SG 11201400218Y A SG11201400218Y A SG 11201400218YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- osteoblastic function
- increasing osteoblastic
- increasing
- function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161532772P | 2011-09-09 | 2011-09-09 | |
| US201161535441P | 2011-09-16 | 2011-09-16 | |
| PCT/AU2012/001062 WO2013033777A1 (en) | 2011-09-09 | 2012-09-07 | Methods for increasing osteoblastic function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400218YA true SG11201400218YA (en) | 2014-03-28 |
Family
ID=47831362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400218YA SG11201400218YA (en) | 2011-09-09 | 2012-09-07 | Methods for increasing osteoblastic function |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9642878B2 (en) |
| EP (2) | EP2753342B1 (en) |
| JP (2) | JP6363950B2 (en) |
| KR (1) | KR102009056B1 (en) |
| CN (2) | CN108635377B (en) |
| AU (2) | AU2012307086B2 (en) |
| CA (1) | CA2847575C (en) |
| ES (1) | ES2676886T3 (en) |
| HK (2) | HK1197183A1 (en) |
| IL (1) | IL231327A0 (en) |
| SG (1) | SG11201400218YA (en) |
| TR (1) | TR201809635T4 (en) |
| WO (1) | WO2013033777A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2729562B1 (en) | 2011-07-06 | 2018-04-18 | Cell Therapy Limited | Progenitor cells of mesodermal lineage |
| AU2012307086B2 (en) * | 2011-09-09 | 2016-05-26 | Mesoblast, Inc. | Methods for increasing osteoblastic function |
| KR20170095932A (en) * | 2014-12-23 | 2017-08-23 | 메조블라스트 인터내셔널 에스에이알엘 | Method for treating heart failure |
| CN110613736A (en) * | 2019-10-30 | 2019-12-27 | 广州陈运贤生命科技有限公司 | Composition and preparation for treating bone marrow failure diseases, preparation method and application |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| DE69233013T2 (en) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | ADENOVIRUS MEDIATED GENTRANSFER INTO THE GASTROINTESTINAL TRACT |
| AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
| DE19939781C2 (en) | 1999-08-21 | 2003-06-18 | Schott Glas | Skull crucible for melting or refining inorganic substances, especially glasses and glass ceramics |
| WO2006029347A2 (en) * | 2004-09-03 | 2006-03-16 | University Of Maryland, Baltimore | Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis |
| AU2005287855B2 (en) * | 2004-09-24 | 2011-06-16 | Mesoblast, Inc. | Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
| CN101506355B (en) * | 2004-09-24 | 2012-06-27 | 成血管细胞系统公司 | Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
| ES2654428T3 (en) | 2005-04-12 | 2018-02-13 | Mesoblast, Inc. | Isolation of adult multipotential cells by non-tissue alkaline phosphatase |
| JP2006346420A (en) | 2005-06-13 | 2006-12-28 | Univ Nagoya | Grafting material and bone improver |
| GB0600972D0 (en) * | 2006-01-18 | 2006-03-01 | Univ Leeds | Enrichment of cells |
| EP2089510B1 (en) * | 2006-06-28 | 2021-02-24 | The University of Medicine and Dentistry of New Jersey | Amnion-derived stem cells and uses thereof |
| CN101835479A (en) * | 2007-07-25 | 2010-09-15 | 佰欧益有限公司 | Differentiation of multi-lineage progenitor cells to chondrocytes |
| KR101688449B1 (en) | 2007-08-06 | 2016-12-21 | 메소블라스트, 아이엔씨. | Methods of generating, repairing and/or maintaining connective tissue in vivo |
| US7639486B2 (en) * | 2007-12-13 | 2009-12-29 | International Business Machines Corporation | Rack system providing flexible configuration of computer systems with front access |
| PL2297304T3 (en) * | 2008-05-07 | 2018-01-31 | Bone Therapeutics Sa | Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression |
| US8858932B2 (en) * | 2008-06-25 | 2014-10-14 | Mesoblast, Inc. | Repair and/or reconstitution of invertebral discs |
| CN102971414B (en) * | 2009-12-22 | 2016-01-27 | 新加坡科技研究局 | The treatment of fracture |
| US20120294837A1 (en) * | 2010-02-02 | 2012-11-22 | University Of Rochester | Methods of isolating and culturing mesenchymal stem cells |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| AU2012307086B2 (en) | 2011-09-09 | 2016-05-26 | Mesoblast, Inc. | Methods for increasing osteoblastic function |
-
2012
- 2012-09-07 AU AU2012307086A patent/AU2012307086B2/en active Active
- 2012-09-07 KR KR1020147007543A patent/KR102009056B1/en active IP Right Grant
- 2012-09-07 ES ES12829951.8T patent/ES2676886T3/en active Active
- 2012-09-07 EP EP12829951.8A patent/EP2753342B1/en active Active
- 2012-09-07 EP EP18160218.6A patent/EP3351256A1/en not_active Withdrawn
- 2012-09-07 WO PCT/AU2012/001062 patent/WO2013033777A1/en active Application Filing
- 2012-09-07 US US14/343,730 patent/US9642878B2/en active Active
- 2012-09-07 TR TR2018/09635T patent/TR201809635T4/en unknown
- 2012-09-07 CN CN201810437581.3A patent/CN108635377B/en active Active
- 2012-09-07 SG SG11201400218YA patent/SG11201400218YA/en unknown
- 2012-09-07 CA CA2847575A patent/CA2847575C/en active Active
- 2012-09-07 JP JP2014528798A patent/JP6363950B2/en active Active
- 2012-09-07 CN CN201280043642.9A patent/CN103857401B/en active Active
-
2014
- 2014-03-05 IL IL231327A patent/IL231327A0/en unknown
- 2014-10-27 HK HK14110739.9A patent/HK1197183A1/en unknown
-
2016
- 2016-08-24 AU AU2016219601A patent/AU2016219601A1/en not_active Abandoned
-
2017
- 2017-04-12 US US15/485,637 patent/US20170274016A1/en not_active Abandoned
- 2017-05-09 JP JP2017093210A patent/JP6444448B2/en active Active
-
2019
- 2019-01-24 HK HK19101230.7A patent/HK1259180A1/en unknown
- 2019-07-02 US US16/460,734 patent/US11135249B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013033777A1 (en) | 2013-03-14 |
| HK1259180A1 (en) | 2019-11-29 |
| AU2016219601A1 (en) | 2016-09-08 |
| AU2012307086B2 (en) | 2016-05-26 |
| JP2017171675A (en) | 2017-09-28 |
| ES2676886T3 (en) | 2018-07-25 |
| AU2012307086A1 (en) | 2013-05-02 |
| KR102009056B1 (en) | 2019-08-08 |
| HK1197183A1 (en) | 2015-01-09 |
| US11135249B2 (en) | 2021-10-05 |
| CN108635377B (en) | 2022-06-24 |
| CA2847575C (en) | 2021-10-19 |
| EP2753342A1 (en) | 2014-07-16 |
| EP2753342A4 (en) | 2015-03-11 |
| CN108635377A (en) | 2018-10-12 |
| EP3351256A1 (en) | 2018-07-25 |
| US20170274016A1 (en) | 2017-09-28 |
| JP6363950B2 (en) | 2018-07-25 |
| KR20140082660A (en) | 2014-07-02 |
| US20190343887A1 (en) | 2019-11-14 |
| JP6444448B2 (en) | 2018-12-26 |
| CN103857401A (en) | 2014-06-11 |
| CA2847575A1 (en) | 2013-03-14 |
| JP2014525466A (en) | 2014-09-29 |
| US20140363404A1 (en) | 2014-12-11 |
| IL231327A0 (en) | 2014-04-30 |
| US9642878B2 (en) | 2017-05-09 |
| CN103857401B (en) | 2018-06-05 |
| EP2753342B1 (en) | 2018-04-11 |
| TR201809635T4 (en) | 2018-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3505720T3 (en) | Cementering under styret tryk | |
| DK3798230T3 (en) | Terapeutiske antistoffer | |
| EP2790561A4 (en) | Dishmachine | |
| EP2755962A4 (en) | Azaindazoles | |
| EP2715659A4 (en) | Überfeed | |
| EP2754063A4 (en) | Smb2 scaleout | |
| EP2723631A4 (en) | Quadfolier | |
| EP2776444A4 (en) | Dihydropteridinones | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| GB201117538D0 (en) | Methods | |
| EP2695208A4 (en) | Micro-thermocouple | |
| HK1259180A1 (en) | Method for increasing osteoblastic function | |
| EP2679138A4 (en) | Endsoscope | |
| EP2708561A4 (en) | Bio-pin | |
| DK2770906T3 (en) | Applanationstonometer | |
| EP2684382A4 (en) | Earpuff | |
| EP2698098A4 (en) | Campimeter | |
| EP2694655A4 (en) | pAVEC | |
| EP2702929A4 (en) | Campimeter | |
| GB201100001D0 (en) | TidySqueeze2 | |
| AU4540P (en) | BUNNAN Baloskion tetraphyllum | |
| AU5171P (en) | Sunparamiho Mandevilla xamabilis | |
| AU5031P (en) | BESYS Beschorneria yuccoides | |
| AU5026P (en) | Goldstrike Agapanthus inapertus | |
| ZA201206269B (en) | Pylon |